Peer-reviewed articles

Di Carlo V, Eberle A, Stiller C, et al. Sex differences in survival from melanoma of the skin: The role of age, anatomic location and stage at diagnosis: A CONCORD-3 study in 59 countries. European Journal of Cancer. 2025;217:115213. doi:10.1016/j.ejca.2024.115213

Botta L, Didonè F, Lopez-Cortes A, et al. International benchmarking of stage at diagnosis for six childhood solid tumours (the BENCHISTA project): a population-based, retrospective cohort study. The Lancet Child & Adolescent Health. 2025;9(2):89-99. doi:10.1016/S2352-4642(24)00302-X

Vener C, Lillini R, De Angelis R, et al. Long-term survival for myeloid neoplasms and national health expenditure: A EUROCARE-6 retrospective, population-based study. Eur J Cancer. 2025;220:115231. doi:10.1016/j.ejca.2025.115231

Trama A, Bernasconi A, Cañete A, et al. Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study. Eur J Cancer. 2025;214:115147. doi:10.1016/j.ejca.2024.115147

White P, Brennan A, McDevitt J, et al. Screen-detected breast cancer and cancer stage by area-level deprivation: a descriptive analysis using data from the National Cancer Registry Ireland. Eur J Public Health. Published online December 13, 2024:ckae204. doi:10.1093/eurpub/ckae204

Zhang M, Kelly C, McCarthy T, et al. Examining the COVID-19 impact on cancer surgery in Ireland using three national data sources. Glob Epidemiol. 2024;8:100159. doi:10.1016/j.gloepi.2024.100159

Indini A, Didoné F, Massi D, et al. Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results. European Journal of Cancer. 2024;213:115079. doi:10.1016/j.ejca.2024.115079

Barrett PM, Daly FP, Zhang M, et al. The impact of the COVID-19 pandemic on the dispensing of systemic anti-cancer therapy (SACT) in Ireland: A population based study. Public Health Pract (Oxf). 2024;8:100557. doi:10.1016/j.puhip.2024.100557

Morgan E, O’Neill C, Shah R, et al. Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 2024;26(1):171. doi:10.1186/s13058-024-01881-y

Virgili G, Capocaccia R, Botta L, et al. Survival and Health Care Burden of Children With Retinoblastoma in Europe. JAMA Ophthalmol. 2024;142(11):1062. doi:10.1001/jamaophthalmol.2024.4140

Bambury N, Zhang M, McCarthy T, et al. Impact of the COVID-19 pandemic on electronic referrals to rapid access clinics for suspected breast, lung and prostate cancers in Ireland. Eur J Public Health. 2024;34(5):908-913. doi:10.1093/eurpub/ckae092

Morgan E, O’Neill C, Bardot A, et al. Collecting Long-Term Outcomes in Population-Based Cancer Registry Data: The Case of Breast Cancer Recurrence. JCO Glob Oncol. 2024;10:e2400249. doi:10.1200/GO-24-00249

Botta L, Capocaccia R, Bernasconi A, et al. Estimating cure and risk of death from other causes of cancer patients: EUROCARE-6 data on head & neck, colorectal, and breast cancers. Eur J Cancer. 2024;208:114187. doi:10.1016/j.ejca.2024.114187

Millar SR, Mohamed MB, Mykytiv V, et al. Blood Cancer Network Ireland (BCNI) and National Cancer Registry Ireland (NCRI) collaboration: challenges and utility of an Enhanced Blood Cancer Outcomes Registry (EBCOR) pilot. Ir J Med Sci. Published online July 20, 2024. doi:10.1007/s11845-024-03756-9

Sexton GP, Hintze JM, Walsh P, et al. Epidemiology and management of oral cavity squamous cell carcinoma in Ireland. Am J Otolaryngol. 2024;45(3):104235. doi:10.1016/j.amjoto.2024.104235

Sant M, Vener C, Lillini R, et al. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study. The Lancet Oncology. 2024;25(6):731-743. doi:10.1016/S1470-2045(24)00141-4

Trama A, Botta L, Stiller C, et al. Survival of European adolescents and young adults diagnosed with cancer in 2010–2014. European Journal of Cancer. 2024;202:113558. doi:10.1016/j.ejca.2024.113558

Lopez-Cortes A, Didonè F, Botta L, et al. Corrigendum: Cancer data quality and harmonization in Europe: The experience of the BENCHISTA Project – International Benchmarking of Childhood Cancer Survival by Stage. Front Oncol. 2024;14:1397101. doi:10.3389/fonc.2024.1397101

Keogh RJ, Harvey H, Brady C, et al. Dealing with digital paralysis: Surviving a cyberattack in a National Cancer center. J Cancer Policy. 2024;39:100466. doi:10.1016/j.jcpo.2023.100466

De Angelis R, Demuru E, Baili P, et al. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study. The Lancet Oncology. 2024;25(3):293-307. doi:10.1016/S1470-2045(23)00646-0

McFeely O, Walsh PM, Desmond R, et al. Incidence of cutaneous T-cell lymphoma in the Republic of Ireland between 1994 and 2019. J Eur Acad Dermatol Venereol. 2024;38(2):e145-e147. doi:10.1111/jdv.19497

Sexton GP, Walsh P, Moriarty F, Lennon P, O’Neill JP. Survival in an era of organ preservation: an update on laryngeal cancer in Ireland. Eur Arch Otorhinolaryngol. 2023;280(10):4587-4595. doi:10.1007/s00405-023-08055-0

Botta L, Matsuda T, Charvat H, et al. Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure. Front Oncol. 2023;13:1219111. doi:10.3389/fonc.2023.1219111

Matz M, Valkov M, Šekerija M, et al. Worldwide trends in esophageal cancer survival, by sub?site, morphology, and sex: an analysis of 696,974 adults diagnosed in 60 countries during 2000?2014 (CONCORD?3). Cancer Communications. 2023;43(9):963-980. doi:10.1002/cac2.12457

Lopez-Cortes A, Didonè F, Botta L, et al. Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project – international benchmarking of childhood cancer survival by stage. Front Oncol. 2023;13:1232451. doi:10.3389/fonc.2023.1232451